About Gen-Plus
Gen-Plus is a privately owned small and medium-sized enterprise (SME) with the goal of driving new innovations in the field of formulation and technology concepts for the pharmaceutical industry on a contract basis. The R&D laboratory develops solid and semi-solid dosage forms as well as patch and thin films from the idea to clinical samples under GMP conditions. Another focus is on consulting services for pharmaceutical issues.
In addition to NCE formulations for Big Pharma, Gen-Plus also develops innovative design-arounds and generic-plus concepts for generics. Numerous OTC and NEM projects are also in the pipeline. Recently, Gen-Plus has also been working on non-sterile biotech projects and liposomes.
The GMP laboratory has a size of approx. 1000 m² and currently employs 15 people in galenics and analytics. Highly potent active ingredients are also processed in specially manufactured isolators in the special laboratory, as are narcotics (BTM). In addition, Gen-Plus has a comprehensive quality management system.
There has been constant investment in new technologies in the state-of-the-art laboratory, including hot melt extrusion, lyophilization, amorphization of API's, micro/nanoemulsions and many more. Recent innovations deal with alternative administration technologies, e.g. via laser, or with 2D/3D printing technology.
Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of company presentation. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.
- Focus : Service
- Industry : Pharma
